ATORVASTATIN CALCIUM
- Product NDC
- 43353-115
- 11-digit product format
- 433530115
- Labeler code
- 43353
- Product ID
- 43353-115_0b2503ae-dca7-4c5f-8622-2c9366aab351
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA090548
- Marketing category
- ANDA
- Marketing start
- 2012-05-29
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43353-115-45 | ATORVASTATIN CALCIUM | 45 in 1 BOTTLE | TABLET, FILM COATED | 45 | | 1 |
| 43353-115-60 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-115 | ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC, 2 package rows | 20160706_b30ec062-d56b-49b4-92ef-0b8346b3785b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 43353-115-45 | 43353011545 | 45 in 1 BOTTLE | Historical |
| 43353-115-60 | 43353011560 | 90 in 1 BOTTLE | Historical |